Cargando…
The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
BACKGROUND AND AIMS: Multiple sclerosis (MS) is the most common neuroimmunological disease of the central nervous system in young adults. Despite recommended contraception, unplanned pregnancies can occur in women of childbearing age with MS. MS- and comorbidities-related multimedication in these pa...
Autores principales: | Frahm, Niklas, Hecker, Michael, Langhorst, Silvan Elias, Mashhadiakbar, Pegah, Haker, Marie-Celine, Zettl, Uwe Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758868/ https://www.ncbi.nlm.nih.gov/pubmed/33425014 http://dx.doi.org/10.1177/1756286420969501 |
Ejemplares similares
-
Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022) -
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
por: Hecker, Michael, et al.
Publicado: (2022) -
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy
por: Haker, Marie-Celine, et al.
Publicado: (2023) -
Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
por: Baldt, Julia, et al.
Publicado: (2023) -
Associated factors of potential drug-drug interactions and drug–food
interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)